NO992228L - 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor - Google Patents

1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor

Info

Publication number
NO992228L
NO992228L NO992228A NO992228A NO992228L NO 992228 L NO992228 L NO 992228L NO 992228 A NO992228 A NO 992228A NO 992228 A NO992228 A NO 992228A NO 992228 L NO992228 L NO 992228L
Authority
NO
Norway
Prior art keywords
hiv protease
phenylmethylcyclic
aminoindazol
protease inhibitor
urea suitable
Prior art date
Application number
NO992228A
Other languages
English (en)
Norwegian (no)
Other versions
NO992228D0 (no
Inventor
James David Rodgers
Iii Robert Frank Kaltenbach
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO992228D0 publication Critical patent/NO992228D0/no
Publication of NO992228L publication Critical patent/NO992228L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO992228A 1996-11-08 1999-05-07 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor NO992228L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974596P 1996-11-08 1996-11-08
US74710496A 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
NO992228D0 NO992228D0 (no) 1999-05-07
NO992228L true NO992228L (no) 1999-06-07

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992228A NO992228L (no) 1996-11-08 1999-05-07 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor

Country Status (21)

Country Link
EP (1) EP0937067B1 (hu)
JP (1) JP2001503428A (hu)
KR (1) KR20000053122A (hu)
CN (1) CN1235602A (hu)
AT (1) ATE244714T1 (hu)
AU (1) AU5165198A (hu)
BR (1) BR9712910A (hu)
CA (1) CA2270966A1 (hu)
CZ (1) CZ157599A3 (hu)
DE (1) DE69723456T2 (hu)
EA (1) EA199900452A1 (hu)
EE (1) EE9900188A (hu)
ES (1) ES2202645T3 (hu)
HU (1) HUP9904676A2 (hu)
IL (1) IL129727A0 (hu)
LV (1) LV12375B (hu)
NO (1) NO992228L (hu)
PL (1) PL333421A1 (hu)
SI (1) SI20074A (hu)
SK (1) SK59699A3 (hu)
WO (1) WO1998020008A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518094A (ja) * 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Hivプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
UA94733C2 (ru) 2006-01-31 2011-06-10 Эррей Биофарма Инк. Ингибиторы киназы и способы их использования

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
CZ157599A3 (cs) 1999-11-17
EE9900188A (et) 1999-12-15
IL129727A0 (en) 2000-02-29
SK59699A3 (en) 1999-12-10
CA2270966A1 (en) 1998-05-14
LV12375A (lv) 1999-11-20
CN1235602A (zh) 1999-11-17
SI20074A (sl) 2000-04-30
DE69723456T2 (de) 2004-05-27
JP2001503428A (ja) 2001-03-13
NO992228D0 (no) 1999-05-07
EA199900452A1 (ru) 2000-02-28
KR20000053122A (ko) 2000-08-25
EP0937067B1 (en) 2003-07-09
AU5165198A (en) 1998-05-29
BR9712910A (pt) 2000-03-21
DE69723456D1 (de) 2003-08-14
WO1998020008A1 (en) 1998-05-14
EP0937067A1 (en) 1999-08-25
ES2202645T3 (es) 2004-04-01
LV12375B (en) 2000-04-20
ATE244714T1 (de) 2003-07-15
HUP9904676A2 (hu) 2000-06-28
PL333421A1 (en) 1999-12-06

Similar Documents

Publication Publication Date Title
NO932620L (no) Amindiol-proteaseinhibitorer
EA199900907A1 (ru) 4,4-дизамещенные 3,4-дигидро-2(1н)-хиназолиноны, полезные в качестве ингибиторов обратной транскриптазы вич
BG100455A (en) Hiv protease inhibitors
DK0816376T3 (da) Thrombininhibitorer som antikoagulante midler
ES2184763T3 (es) Inhibidores de trombina.
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
DK0528858T3 (da) Inhibitorer af dipeptidyl-aminopeptidase type IV
BR9908280A (pt) Inibidores de enzimas de fosfolipase
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DK0656887T3 (da) Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
WO1995033464A3 (en) Retroviral protease inhibitor combinations
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
BR9810177A (pt) Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostos
SE9602263D0 (sv) New amino acid derivatives
DE69625183T2 (de) Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen
EE200300168A (et) Tripeptidüülpeptidaasi inhibiitorid, nende valmistamine ja kasutamine ravimina ning neid sisaldav farmatseutiline kompositsioon
DK0763017T3 (da) N-(3-amino-2-hydroxybutyl)sulfonamidderivater som HIV-proteaseinhibitorer
ES2171945T3 (es) Derivados aromaticos de amidina que sirven de inhibidores selectivos de la trombina.
BR0007453A (pt) Composto, formulação farmacêutica, uso de umcomposto, método de tratamento de uma condiçãoonde a inibição da trombina é requerida e,processo de preparação de um composto
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
NO992228L (no) 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor
PT975588E (pt) Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
NO992229L (no) (4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application